CML is a myeloid neoplasm caused by the BCR-ABL fusion gene that causes dysregulated cellular proliferation and apoptosis resistance via interference in downstream signaling pathways. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.